Clinical Trial Update: Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated a combination of sitagliptin and lansoprazole to restore pancreatic beta cell function in recent-onset Type 1 Diabetes; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lansoprazole (Lansoprazole)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Sanford Health | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2017-09-18